Halozyme Therapeutics shares owned by Lombard Odier Asset Management
Quarter-by-quarter ownership of Halozyme Therapeutics shares owned by Lombard Odier Asset Management
from 13F filings
Historical chart of Lombard Odier Asset Management investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Lombard Odier Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Halozyme Therapeutics by Lombard Odier Asset Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-09-30 | $1.5M | 1.8M | 0.85 |
2023-06-30 | $1.1M | 1.4M | 0.83 |
2023-03-31 | $35M | 42M | 0.84 |
2022-12-31 | $56M | 42M | 1.32 |
2022-09-30 | $5.3M | 6.3M | 0.85 |
More positions owned by Lombard Odier Asset Management
View all positions for Lombard Odier Asset Management